KALA BIO, Inc.
Last verified 2026-05-06. JSON
| Total raised | $10.7M |
|---|---|
| Latest round | Funding round, $10.7M, 2024-12-31 |
| Founded | unknown |
| Headquarters | Arlington, Massachusetts |
| Industry | biotechnology |
| Stage | unknown |
| Website | kalarx.com |
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-12-31 | Funding round | $10.7M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $10.7M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $10.7M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | kalarx.com, read 2026-05-06 |
| Description | self-reported | kalarx.com, read 2026-05-06 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $10.7M, 2024-12-31 → Funding round, $10.7M, 2024-12-31, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $10.7M, 2024-12-31 → Funding round, $10.7M, 2024-12-31 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes